中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/05/23 | 3,734 | 3,758 | 3,692 | 3,742 | +41 | +1.1% | 3,115,700 |
| 2023/05/22 | 3,607 | 3,707 | 3,601 | 3,701 | +94 | +2.6% | 2,801,400 |
| 2023/05/19 | 3,620 | 3,622 | 3,588 | 3,607 | +19 | +0.5% | 1,994,000 |
| 2023/05/18 | 3,594 | 3,613 | 3,585 | 3,588 | -3 | -0.1% | 1,914,700 |
| 2023/05/17 | 3,614 | 3,621 | 3,581 | 3,591 | -37 | -1% | 2,115,100 |
| 2023/05/16 | 3,633 | 3,638 | 3,614 | 3,628 | +15 | +0.4% | 2,051,000 |
| 2023/05/15 | 3,592 | 3,616 | 3,580 | 3,613 | +38 | +1.1% | 1,525,300 |
| 2023/05/12 | 3,558 | 3,589 | 3,548 | 3,575 | +43 | +1.2% | 2,407,600 |
| 2023/05/11 | 3,545 | 3,554 | 3,522 | 3,532 | -46 | -1.3% | 1,623,600 |
| 2023/05/10 | 3,598 | 3,604 | 3,578 | 3,578 | -40 | -1.1% | 1,565,500 |
| 2023/05/09 | 3,562 | 3,622 | 3,562 | 3,618 | +30 | +0.8% | 2,232,600 |
| 2023/05/08 | 3,601 | 3,634 | 3,578 | 3,588 | -15 | -0.4% | 2,188,800 |
| 2023/05/02 | 3,585 | 3,630 | 3,563 | 3,603 | +61 | +1.7% | 2,318,800 |
| 2023/05/01 | 3,519 | 3,552 | 3,515 | 3,542 | +38 | +1.1% | 2,034,000 |
| 2023/04/28 | 3,493 | 3,554 | 3,479 | 3,504 | +75 | +2.2% | 3,791,600 |
| 2023/04/27 | 3,391 | 3,429 | 3,380 | 3,429 | +14 | +0.4% | 1,714,500 |
| 2023/04/26 | 3,437 | 3,445 | 3,395 | 3,415 | -26 | -0.8% | 1,868,000 |
| 2023/04/25 | 3,433 | 3,449 | 3,421 | 3,441 | +44 | +1.3% | 2,373,900 |
| 2023/04/24 | 3,363 | 3,427 | 3,351 | 3,397 | +115 | +3.5% | 3,249,400 |
| 2023/04/21 | 3,249 | 3,290 | 3,241 | 3,282 | +14 | +0.4% | 1,714,800 |
| 2023/04/20 | 3,305 | 3,310 | 3,265 | 3,268 | -51 | -1.5% | 2,382,600 |
| 2023/04/19 | 3,329 | 3,345 | 3,306 | 3,319 | -32 | -1% | 2,098,800 |
| 2023/04/18 | 3,340 | 3,351 | 3,328 | 3,351 | +33 | +1% | 1,746,200 |
| 2023/04/17 | 3,322 | 3,339 | 3,307 | 3,318 | -23 | -0.7% | 1,521,400 |
| 2023/04/14 | 3,325 | 3,341 | 3,305 | 3,341 | +29 | +0.9% | 2,986,900 |
| 2023/04/13 | 3,277 | 3,312 | 3,265 | 3,312 | +62 | +1.9% | 2,426,000 |
| 2023/04/12 | 3,262 | 3,279 | 3,248 | 3,250 | +5 | +0.2% | 1,495,100 |
| 2023/04/11 | 3,235 | 3,282 | 3,228 | 3,245 | +10 | +0.3% | 2,530,600 |
| 2023/04/10 | 3,235 | 3,256 | 3,230 | 3,235 | +8 | +0.2% | 1,520,800 |
| 2023/04/07 | 3,231 | 3,231 | 3,208 | 3,227 | +4 | +0.1% | 1,619,700 |
| 2023/04/06 | 3,222 | 3,234 | 3,203 | 3,223 | -15 | -0.5% | 3,283,700 |
| 2023/04/05 | 3,319 | 3,325 | 3,238 | 3,238 | -81 | -2.4% | 2,345,100 |
| 2023/04/04 | 3,285 | 3,349 | 3,276 | 3,319 | +69 | +2.1% | 2,729,500 |
| 2023/04/03 | 3,279 | 3,294 | 3,243 | 3,250 | -20 | -0.6% | 1,812,800 |
| 2023/03/31 | 3,251 | 3,275 | 3,227 | 3,270 | +27 | +0.8% | 3,122,200 |
| 2023/03/30 | 3,282 | 3,287 | 3,225 | 3,243 | -39 | -1.2% | 1,947,600 |
| 2023/03/29 | 3,253 | 3,284 | 3,230 | 3,282 | +14 | +0.4% | 2,071,500 |
| 2023/03/28 | 3,281 | 3,292 | 3,253 | 3,268 | -3 | -0.1% | 1,689,900 |
| 2023/03/27 | 3,215 | 3,280 | 3,212 | 3,271 | +51 | +1.6% | 1,864,100 |
| 2023/03/24 | 3,230 | 3,232 | 3,209 | 3,220 | -35 | -1.1% | 1,728,100 |
| 2023/03/23 | 3,288 | 3,294 | 3,246 | 3,255 | -69 | -2.1% | 1,811,500 |
| 2023/03/22 | 3,339 | 3,378 | 3,318 | 3,324 | +13 | +0.4% | 2,293,900 |
| 2023/03/20 | 3,376 | 3,392 | 3,311 | 3,311 | -55 | -1.6% | 2,001,800 |
| 2023/03/17 | 3,343 | 3,372 | 3,335 | 3,366 | +34 | +1% | 3,239,700 |
| 2023/03/16 | 3,280 | 3,332 | 3,267 | 3,332 | +28 | +0.8% | 2,321,900 |
| 2023/03/15 | 3,304 | 3,315 | 3,285 | 3,304 | -2 | -0.1% | 2,297,400 |
| 2023/03/14 | 3,285 | 3,320 | 3,263 | 3,306 | -22 | -0.7% | 2,345,900 |
| 2023/03/13 | 3,331 | 3,348 | 3,308 | 3,328 | -16 | -0.5% | 1,609,000 |
| 2023/03/10 | 3,397 | 3,398 | 3,331 | 3,344 | -53 | -1.6% | 3,659,500 |
| 2023/03/09 | 3,378 | 3,405 | 3,377 | 3,397 | +12 | +0.4% | 1,623,700 |
501～
550
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 761,900円 | +1.7% | +5.0% | 3.28% | 30.58倍 | 6.59倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 武 田 | 429,500円 | -1.1% | +75.3% | 4.66% | 29.42倍 | 0.97倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 348,500円 | +6.0% | +4.0% | 2.24% | 21.64倍 | 4.00倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 大塚ＨＤ | 677,800円 | +2.2% | +10.2% | 1.77% | 13.02倍 | 1.31倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
